ArticleThe National medical journal of India

Short-duration adjuvant trastuzumab therapy in human epidermal growth factor receptor 2-positive breast cancers: Has its time come?

Ajay Gogia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.